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801-3 Anemia Worsens Prognosis After Primary Angioplasty 
in Acute Myocardial Infarction: Analysis From the 
CADILLAC Trial
Eugenia Nikolsky, Amir Halkin, Eve A. Aymong, Roxana Mehran, Alexandra Lansky, 
Cindy L. Grines, Mark Turco, David A. Cox, Eulogio Garcia, James E. Tcheng, John J. 
Griffin, Giulio Guagliumi, Thomas Stuckey, David A. Cohen, Barry D. Rutherford, Gregg 
W. Stone, The Cardiovascular Research Foundation, New York City, NY
Background The significance of anemia in patients with acute myocardial infarction (AMI)
undergoing primary angioplasty is unknown. We examined the impact of baseline ane-
mia on outcomes after percutaneous coronary intervention (PCI) in AMI from the CADIL-
LAC trial. Methods and Results. Anemia by World Health Organization criteria
(hematocrit <39% for men and <36% for women) was present in 260 of 2027 randomized
patients (12.8%). Patients with vs. without anemia were older, more frequently female,
and had a higher prevalence of diabetes and hypertension. At discharge patients with
anemia were less likely to be treated with aspirin (91.2% vs. 96%, P=0.0012) and beta-
blockers (67.7% vs. 79.2%, P<0.001). In both males and especially females anemia was
associated with increased 30-day and 1-year mortality, and women with anemia had an
increased rate of stroke (Table). One-year rates of reinfarction (2.9% vs. 2.3%) and target
vessel revascularization (10.8% vs. 13.7%) were similar in patients with vs. without ane-
mia, respectively. By multivariate analysis lower hematocrit was an independent predictor
of 30-day mortality (HR 0.80, P=0.04), one-year mortality (HR 0.83, P=0.02) and dis-
abling stroke (HR 0.39, P=0.004). Conclusions. Anemia at baseline in patients with AMI
treated with PCI is common, and is associated with an adverse early and late prognosis.
Anemic patients are less likely to be treated with medications proven to improve out-
comes after AMI, which adversely affects their survival.
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801-4 High Risk Genotypes for Myocardial Infarction Are More 
Common in African Americans Than European 
Americans
David E. Lanfear, Sharon Marsh, Sharon Cresci, John A. Spertus, Howard L. McLeod, 
Washington University School of Medicine, Saint Louis, MO, Mid-America Heart Institute, 
Kansas City, MO
Background: African Americans have higher rates of cardiovascular disease than their
white counterparts. Whether this greater burden is due to genetic or environmental fac-
tors is not known. Recent large case-control studies have identified polymorphisms in
connexin-37 (GJA4), plasminogen activator inhibitor-1 (PAI-1), and stromelysin-1
(MMP3) as risk factors for myocardial infarction (MI). We tested the frequency of these
polymorphisms in black and white patients to provide new insights into the frequencies of
high-risk genotypes in different racial groups.
Methods: Genomic DNA from population samples of 95 African Americans (AA) and 95
European Americans (EA) was used for genotyping. DNA containing the polymorphism
of interest was amplified using the polymerase chain reaction, followed by genotyping
using Pyrosequencing.
Results: All three MI-risk genotypes were observed in both populations. All were in
Hardy-Weinberg equilibrium. The frequencies of the 'high risk' genotypes were: GJA4
C1019T T/T: AA-20%, EA-7% (p=0.015); PAI-1 -668delG G/G: AA-56%, EA-16%
(p<0.001); MMP3 -1171delA A/A: AA-76.9%, EA-24% (p<0.001). In the EA group the
likelihood of having 2 or more high-risk genotypes was 3.2%, compared to 47% in the AA
group (p<0.001). 8.4% of AA had all three high risk genotypes compared with 0% in the
EA group (p=0.004).
Conclusions: We found higher frequencies of three disease-associated genotypes in AA
as compared to EA. Our observed frequency for the PAI-1 polymorphism is consistent
with findings of other investigators. This is the first frequency analysis reported for the
MMP3 and GJA4 polymorphisms in AA subjects. Importantly, our results also indicate
that the presence of multiple high-risk genotypes is significantly more common among
AA than EA. These differences in disease-associated genotype frequencies may contrib-
ute to racial disparities in cardiovascular disease burden. Further studies are needed to
assess both the risk associated with these compound genotypes, as well as their prog-
nostic importance among those with established disease.
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801-5 Inherent Sex Differences in the Ischemia-Induced 
Myocardial Inflammatory Response of Proestrus 
Females and Normal Males
Meijing Wang, Lauren Baker, Ben Tsai, Kirstan K. Meldrum, John W. Brown, Daniel R. 
Meldrum, Indiana University School of Medicine, Indianapolis, IN, Indiana Center for 
Vascular Biology and Medicine, Indianapolis, IN
Background.Although it is well established that there are gender differences in the pro-
gression of heart disease, little information exists regarding the mechanisms of inherent
sex differences in myocardial responses to acute injury. Recent evidence indicates that
the female inflammatory response may explain differential survival following sepsis and
trauma. Indeed, the cardiac inflammatory response, especially p38 MAPK activation and
IL-1/IL-6 production, is an important component of myocardial injury. We hypothesized
that proestrus females would demonstrate: a different myocardial functional recovery fol-
lowing ischemia; and, 2) inherent differences in p38 MAPK activation and IL-1/IL-6 pro-
duction.
Methods. Langendorff perfused rat hearts (normal age matched males and proestrus
females) were subjected to 27 min ischemia and 40 min reperfusion.. Developed pres-
sure (DP) was continously recorded. Myocardium was assessed for p38 activation (phos-
pho-p38, western), and IL-1/IL-6 mRNA production (RT-PCR). STATS: ANOVA with
Bonferroni-Dunn (P<0.05=significance).
Results: The recovery of left ventricular developed pressure in female rat after I/R was
much higher than that in male rat (female: 74.6%±0.12, n=5; male: 43.1%±0.04, n=5;
p<0.05). IL-1 and IL-6 mRNA levels were significantly lower in female heart than that in
male heart after I/R (IL-1α, female 0.41±0.018, male 0.5±0.013 p<0.005; IL-1β, female
0.49±0.022, male 0.69±0.026 p<0.001; IL-6, female 0.6±0.02, male 0.76±0.015 p<0.001)
. More p38 MAPK activation existed in male rat heart.
Conclusions: 1) Sex differences exist in normal male and female myocardial responses
to ischemia; 2) following ischemia, proestrus females demonstrated less p38 MAPK acti-
vation than males; 3) proestrus females produce less IL-1 and IL-6 than normal, aged-
matched males subjected to the same insult.
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809-1 The Changing Profile of First Reoperative Coronary 
Artery Bypass Surgery: Trends Over 17 Years in 2,770 
Patients
Zefeng Zhang, William S. Weintraub, Emir Veledar, Ellis L. Jones, John D. Puskas, 
Joseph M. Craver, Robert A. Guyton, Emory University School of Medicine, Atlanta, GA
Background: Re-operative coronary artery bypass grafting (CABG) is an increasing part
of current surgical practice. Few data are available regarding the changing profile of
patients undergoing re-operative CABG and trends of its outcomes. Methods: Prospec-
tively entered preoperative data of 2770 patients undergoing first re-operative CABG at
Emory University Hospitals, from 1985 to 2001, were retrospectively analyzed. Categori-
cal and continuous variables were compared using the chi-square and analysis of covari-
ance, respectively. Results: The mean age was 63.4 years and 85% were male. There
was a statistically significant trend over time for patients to be older and sicker by multiple
criteria, including presence of diabetes, hypertension, previous myocardial infarction, left
ventricular ejection fraction, 3-vessel and left main disease. More operations were per-
formed electively after year 1990. The period between first and re-operative CABG
increased significantly, post-procedure length of stay decreased dramatically over time
while in-hospital mortality has been stable during the study period (see Table). 
30-day and 1-year outcomes
Endpoint Males Females
With 
anemia
N=177
Without 
anemia
N=1306 P-value
With 
anemia
N=83
Without 
anemia
N=461 P-value
Mortality (%)
At 30 days 2.9 0.9 0.04 12.0 3.0 0.0002
At 1 year 5.8 2.7 0.03 17.0 5.8 <0.0001
Disabling stroke (%)
At 30 days 0.0 0.0 - 2.6 0.2 0.01
At 1 year 1.2 0.4 0.16 4.0 0.2 0.0005
